TY - JOUR
T1 - Regulation of the adaptive immune system by innate lymphoid cells.
AU - Hepworth, Matthew R
AU - Sonnenberg, Gregory F
N1 - DP5 OD012116, NIH HHS, United StatesDP5OD012116, NIH HHS, United StatesP30 AI045008, NIAID NIH HHS, United StatesP30DK50306, NIDDK NIH HHS, United States
PY - 2014/4
Y1 - 2014/4
N2 - Innate lymphoid cells (ILCs) are a group of lymphocytes that promote rapid cytokine-dependent innate immunity, inflammation and tissue repair. In addition, a growing body of evidence suggests ILCs can influence adaptive immune cell responses. During fetal development a subset of ILCs orchestrate the generation and maturation of secondary lymphoid tissues. Following birth, ILCs continue to modulate adaptive immune cell responses indirectly through interactions with stromal cells in lymphoid tissues and epithelial cells at barrier surfaces. In this review we summarize the current understanding of how ILCs modulate the magnitude and quality of adaptive immune cell responses, and in particular focus on recent evidence suggesting that ILCs can also directly regulate CD4(+) T cells. Further, we discuss the implications that these pathways may have on human health and disease.
AB - Innate lymphoid cells (ILCs) are a group of lymphocytes that promote rapid cytokine-dependent innate immunity, inflammation and tissue repair. In addition, a growing body of evidence suggests ILCs can influence adaptive immune cell responses. During fetal development a subset of ILCs orchestrate the generation and maturation of secondary lymphoid tissues. Following birth, ILCs continue to modulate adaptive immune cell responses indirectly through interactions with stromal cells in lymphoid tissues and epithelial cells at barrier surfaces. In this review we summarize the current understanding of how ILCs modulate the magnitude and quality of adaptive immune cell responses, and in particular focus on recent evidence suggesting that ILCs can also directly regulate CD4(+) T cells. Further, we discuss the implications that these pathways may have on human health and disease.
U2 - 10.1016/j.coi.2014.01.013
DO - 10.1016/j.coi.2014.01.013
M3 - Article
C2 - 24594491
SN - 1879-0372
VL - 27
JO - Current opinion in immunology
JF - Current opinion in immunology
ER -